The second national anti‐tuberculosis drug resistance survey in Tanzania, 2017

The second national anti‐tuberculosis drug resistance survey in Tanzania, 2017–2018

Published:2022-09-11 Issue:10 Volume:27 Page:891-901
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Tropical Med Int Health

Author:

Mutayoba Beatrice Kemilembe¹²,Ershova Julia³,Lyamuya Eligius⁴,Hoelscher Michael²,Heinrich Norbert²,Kilale Andrew Martin⁵,Range Nyagosya Segere⁵,Ngowi Benard James⁶,Ntinginya Nyanda Elias⁷,Mfaume Saidi Mwinjuma⁵,Nkiligi Emmanuel⁸,Doulla Basra⁹,Lyimo Johnson⁸,Kisonga Riziki¹⁰,Kingalu Amri⁸,Lema Yakobo⁵,Kondo Zuwena⁸,Pletschette Michel²

Affiliation:

1. Department of Preventive Services Ministry of Health National AIDS Control Program Dodoma Tanzania

2. Department of Infectious Diseases and Tropical Medicine Medical Center of the University of Munich Munich Germany

3. Division of Global HIV and TB, Global TB Branch US Centers for Disease Control and Prevention Atlanta Georgia USA

4. Department of Microbiology and Immunology Muhimbili University of Health and Allied Sciences Dar es Salaam Tanzania

5. Muhimbili Medical Research Centre National Institute for Medical Research Dar es Salaam Tanzania

6. Mbeya College of Health and Allied Sciences University of Dar es Salaam Mbeya Tanzania

7. National Institute for Medical Research, Mbeya Medical Research Centre Mbeya Tanzania

8. National Tuberculosis and Leprosy Program, Department of Preventive Services Ministry of Health Dodoma Tanzania

9. National Tuberculosis and Leprosy Program Central Tuberculosis Reference Laboratory Dar es Salaam Tanzania

10. Kibong'oto Infectious Diseases Hospital Kilimanjaro Tanzania

Funder

Global Fund to Fight AIDS, Tuberculosis and Malaria

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tmi.13814

Reference39 articles.

1. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment

2. Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression

3. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

4. World Health Organization.Tuberculosis: Multidrug‐resistant tuberculosis (MDR‐TB).2018.https://www.who.int/news-room/questions-and-answers/item/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb). Accessed 13 Mar 2021.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance Rates of Mycobacterium tuberculosis Complex Isolates to Primary Anti-tuberculosis Drugs: A 5-Year Retrospective Study;Genel Tıp Dergisi;2024-04-30

2. Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management;Current Opinion in Pulmonary Medicine;2024-03-15